Eric Eldering Selected Research

Free Radical Scavengers

10/2013

Effect of oxidative stress on respiratory epithelium from children with Down syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Eldering Research Topics

Disease

29	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 08/2008
24	Neoplasms (Cancer) 05/2024 - 07/2004
7	Multiple Myeloma 01/2023 - 09/2010
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 06/2011
4	Leukemia 01/2023 - 01/2019
3	Infections 01/2023 - 02/2012
3	Melanoma (Melanoma, Malignant) 01/2023 - 09/2012
3	Inflammation (Inflammations) 10/2013 - 06/2004
2	Starvation 05/2024 - 01/2020
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023 - 01/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2022
2	Lymphoma (Lymphomas) 01/2022 - 03/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 03/2012
2	Lymphadenopathy 01/2016 - 03/2012
2	Lymphocytosis 01/2016 - 03/2012
2	Virus Diseases (Viral Diseases) 09/2012 - 05/2012
2	Human Influenza (Influenza) 02/2012 - 06/2010
2	Rheumatoid Arthritis 03/2010 - 07/2009
1	Hypoxia (Hypoxemia) 02/2024
1	Bites and Stings (Sting) 01/2023
1	B-Cell Leukemia (Leukemia, B Cell) 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022
1	Adenocarcinoma 12/2022
1	Disease Progression 06/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	COVID-19 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Reinfection 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 10/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2019

Drug/Important Bio-Agent (IBA)

10	venetoclaxIBA 07/2023 - 08/2015
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2009
8	Phosphotransferases (Kinase)IBA 01/2023 - 07/2013
5	AntigensIBA 01/2023 - 01/2010
5	ChemokinesIBA 12/2022 - 09/2009
5	LigandsIBA 01/2017 - 10/2004
4	CytokinesIBA 01/2023 - 11/2013
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
3	Interleukin-8 (Interleukin 8)IBA 12/2022 - 10/2013
3	ibrutinibIBA 12/2021 - 03/2012
3	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021 - 03/2012
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2009 - 08/2008
2	Death Domain ReceptorsIBA 02/2023 - 12/2022
2	1- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA 01/2023 - 01/2016
2	SerpinsIBA 01/2023 - 05/2003
2	Bispecific AntibodiesIBA 01/2022 - 01/2020
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 06/2021 - 06/2011
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 07/2004
2	AntibodiesIBA 08/2015 - 06/2011
2	Dasatinib (BMS 354825)FDA Link 01/2014 - 12/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 09/2002
1	Glutamine (L-Glutamine)FDA Link 05/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024
1	Prostaglandins AIBA 11/2023
1	InterferonsIBA 01/2023
1	Casein Kinase II (Casein Kinase 2)IBA 01/2023
1	Bacterial VaccinesIBA 01/2023
1	serum P-component (CIt)IBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	ThapsigarginIBA 01/2023
1	Ligases (Synthetase)IBA 01/2023
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Cyclin D1IBA 01/2022
1	selicrelumabIBA 06/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Syk KinaseIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	navitoclaxIBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	Rituximab (Mabthera)FDA Link 12/2020
1	Bendamustine Hydrochloride FDA Link 12/2020
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 01/2020
1	RNA Splicing FactorsIBA 01/2020
1	Immunodominant EpitopesIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	idelalisibIBA 10/2019
1	Janus Kinase InhibitorsIBA 10/2019
1	EnzymesIBA 01/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2019
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019
1	pevonedistatIBA 01/2019
1	Platelet-Derived Growth FactorIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	CC ChemokinesIBA 01/2017

Therapy/Procedure

10	Therapeutics 01/2023 - 06/2011
5	Immunotherapy 12/2022 - 09/2009
2	Drug Therapy (Chemotherapy) 01/2020 - 04/2009